Skip to content
Search

Latest Stories

Indian Origin Man Jailed In UK For Illegal Supply Of Medicines

Indian origin man Jagdiep Dhonsi is one among the three jailed in the UK for his involvement in the illegal supply of potentially dangerous prescription-only medicines.

Jagdiep Dhonsi, Amrin Mirza and Shirina Ali were sentenced on Monday (7) at Southwark Crown Court for their involvement in the crime.


Dhonsi was sentenced to 38 months imprisonment, Mirza to 18 months imprisonment, and Ali to 9 months imprisonment for their roles in the crimes.

Following a complex investigation, the Medicines and Healthcare products Regulatory Agency (MHRA) seized more than 300,000 tablets, worth in excess of £315,000.

It is believed these tablets seized represent a fraction of the overall illegal operation.

The trio were convicted of conspiracy to supply unauthorised medicines, including diazepam, zolpidem and zopiclone which are also controlled under the Misuse of Drugs Act, together with other powerful prescription-only medicines.

The supply of medicines from sources outside the regulated supply chain represents a significant public health risk and the criminal group responsible showed a complete disregard for the public’s safety and well-being.

The medicines the group were supplying can have serious side effects; such as, finasteride, which is used to treat hair loss, can lead to foetal abnormalities and sibutramine, which is used as an appetite suppressant was banned in 2010 because of the health risks associated with its use which include cardiovascular events such as heart attack and stroke.

Alastair Jeffrey, MHRA Head of Enforcement said, “Medicines purchased outside the regulated supply chain cannot be guaranteed to meet standards of quality, safety and effectiveness and can present a real risk to public health. Some may contain dangerous ingredients which can have devastating consequences for patients who use them.

“We work to identify those involved in illegal activities with medicines and will use our powers to investigate fully, confiscate assets and, where necessary, prosecute those putting profit before public health,” he added.

More For You

Diageo East African Breweries stake sale

Johnnie Walker whisky and Captain Morgan rum, faces multiple challenges including tariff increases in its key US market

Getty Images

Diageo sells £1.7 billion stake in East African Breweries to Japan's Asahi

Highlights

  • Diageo sells 65 per cent stake in East African Breweries to Asahi Holdings for $2.3 billion (£1.7bn).
  • Deal values EABL at $4.8 bn, making it Japan's largest investment in African alcohol sector.
  • Transaction marks Diageo's complete exit from direct African beer holdings, expected to complete in late 2026.

Diageo, the world's largest spirits group, has agreed to sell its 65 per cent stake in East African Breweries (EABL) to Japan's Asahi Holdings for £1. 7 bn ($2.3 bn), marking its exit from direct African beer operations.

The transaction values EABL, a Nairobi blue chip stock and one of East Africa's top five companies by market capitalisation, at approximately $4.8 bn. The companies described it as the largest investment in an African alcohol business by a Japanese brewer.

Keep ReadingShow less